Shopping Cart is Empty..

$ 0

Coagulation Testing Market by Product (Instruments and Consumables); Application (Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)); Technology (Optical Technology, Mechanical Technology, and Electrochemical Technology); and End User (Hospitals, Clinical Laboratories, and Point-Of-Care Testing) - Global Opportunities and Industry Forecasts, 2017-2023

Diagnostics and Biotech	LI 173488	Pages: NA	Formats*:
Oct 2017 \| 89 Views	Charts: NA	Tables: NA	Author(s): NA

Coagulation tests are medical tests employed to test the hemostasis system. This test is mainly carried out by a coagulometer, which measures and evaluates the speed of clot formation or blood coagulation. These tests avoid the chances of heart attack, thrombosis, and embolism by detecting the presence of blood clots in blood vessels.

The major factors that contribute to the growth of the coagulation testing market include increasing prevalence of blood disorders & cardiovascular diseases, rise in geriatric population, high demand for point of care (POC) coagulation testing, and technological advancements such as faster and easy-to-use devices with advanced sensors technology. However, factors such as high costs of devices and stringent regulatory reforms may restrain the market growth. High demand for disposable coagulation testing products and availability of coagulation testing products in online stores will further provide lucrative market growth opportunities during the forecast period.

The coagulation testing market is segmented on the basis of product, application, technology, end user, and region. On the basis of product, it is divided into instruments and consumables. Based on application, it is segmented into activated clotting time (ACT), thrombin time (TT), partial thromboplastin time (PTT), activated partial thromboplastin time (aPTT), prothrombin time (PT), and other tests, which include platelet count test and fibrinogen testing. Based on technology, the market is classified into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, it is categorized into hospitals, clinical laboratories, point-of-care testing, and other end user. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Alere Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Sysmex Corporation, Thermo Fisher Scientific Inc., Diagnostica Stago Sas, Helena Laboratories, Abbott Laboratories, Medtronic plc, and Micropoint Biosciences.

Key Benefits

The study provides an in-depth analysis of the global coagulation testing market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global coagulation testing market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global coagulation testing market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global coagulation testing market.

Coagulation Testing Market Key Segments:

By Product

Instruments
Consumables

By Application

Activated Clotting Time (ACT)
Thrombin Time (TT)
Partial Thromboplastin Time (PTT)
Activated Partial Thromboplastin Time (aPTT)
Prothrombin Time (PT)
Other Tests

By Technology

Optical Technology
Mechanical Technology
Electrochemical Technology
Others

By End User

Hospitals
Clinical Laboratories
Point-of-Care Testing
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

License Type

Data Pack

Single User PDF

Five User Online/PDF

Enterprise Online/PDF

LICENSE INFO

Users/Sharing

Restricted to one authorized user

Limited to 5 authorized users

Unlimited within company / enterprise

Printing

One Print only

Up to Five Copies

Unlimited within company / enterprise

Delivery Formats

ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

Have questions ?
Speak with analyst

Did you miss anything?
To add more

* Taxes/Fees, If applicable, will be
added at the checkout. All prices in USD.

Need More Information

+1-503-894-6022

help@alliedmarketresearch.com

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Report Title: Coagulation Testing Market by Product (Instruments and Consumables); Application (Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)); Technology (Optical Technology, Mechanical Technology, and Electrochemical Technology); and End User (Hospitals, Clinical Laboratories, and Point-Of-Care Testing) - Global Opportunities and Industry Forecasts, 2017-2023

Select Chapters

Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9

Full Name: *:

Company Name: *:

Job Role: *:

Email: *:

Country: *:

Contact Number: *:

How can we help? *:

Security Code: *:

STAY WITH US

WE ACCEPT

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Chapter: 1 INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models
Chapter: 2 EXECUTIVE SUMMARY 2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW 3.1. MARKET DEFINITION AND SCOPE 3.2. KEY FINDINGS 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. MARKET SHARE ANALYSIS, 2016 3.4. PORTER’S FIVE FORCES ANALYSIS 3.4.1. MARKET DYNAMICS 3.4.2. Drivers 3.4.3. Restraints 3.4.4. Opportunities
Chapter: 4 COAGULATION TESTING MARKET, BY PRODUCT 4.1. OVERVIEW 4.1.1. Market size and forecast 4.2. INSTRUMENTS 4.2.1. Key market trends 4.2.2. Growth factors and opportunities 4.2.3. Market size and forecast 4.3. CONSUMABLES 4.3.1. Key market trends 4.3.2. Growth factors and opportunities 4.3.3. Market size and forecast
Chapter: 5 COAGULATION TESTING MARKET, BY APPLICATION 5.1. OVERVIEW 5.1.1. Market size and forecast 5.2. ACTIVATED CLOTTING TIME (ACT) 5.2.1. Market size and forecast 5.3. THROMBIN TIME (TT) 5.3.1. Market size and forecast 5.4. PARTIAL THROMBOPLASTIN TIME (PTT) 5.4.1. Market size and forecast 5.5. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) 5.5.1. Market size and forecast 5.6. PROTHROMBIN TIME (PT) 5.6.1. Market size and forecast 5.7. OTHERS 5.7.1. Market size and forecast
Chapter: 6 COAGULATION TESTING MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.1.1. Market size and forecast 6.2. OPTICAL TECHNOLOGY 6.2.1. Market size and forecast 6.3. MECHANICAL TECHNOLOGY 6.3.1. Market size and forecast 6.4. ELECTROCHEMICAL TECHNOLOGY 6.4.1. Market size and forecast 6.5. OTHERS 6.5.1. Market size and forecast
Chapter: 7 COAGULATION TESTING MARKET, BY END USER 7.1. OVERVIEW 7.1.1. Market size and forecast 7.2. HOSPITALS 7.2.1. Market size and forecast 7.3. CLINICAL LABORATORIES 7.3.1. Market size and forecast 7.4. POINT-OF-CARE TESTING 7.4.1. Market size and forecast 7.5. OTHER END USER 7.5.1. Market size and forecast
Chapter: 8 COAGULATION TESTING MARKET, BY REGION 8.1. OVERVIEW 8.2. NORTH AMERICA 8.2.1. Key market trends 8.2.2. Key growth factors and opportunities 8.2.3. Market size and forecast 8.2.3.1. U.S. market size and forecast 8.2.3.2. Canada market size and forecast 8.2.3.3. Mexico market size and forecast 8.2.4. North America coagulation testing market by product 8.2.5. North America coagulation testing market by application 8.2.6. North America coagulation testing market by technology 8.2.7. North America coagulation testing market by end user 8.3. EUROPE 8.3.1. Key market trends 8.3.2. Key growth factors and opportunities 8.3.3. Market size and forecast 8.3.3.1. Germany market size and forecast 8.3.3.2. France market size and forecast 8.3.3.3. UK market size and forecast 8.3.3.4. Italy market size and forecast 8.3.3.5. Spain market size and forecast 8.3.3.6. Rest of Europe market size and forecast 8.3.4. Europe coagulation testing market by product 8.3.5. Europe coagulation testing market by application 8.3.6. Europe coagulation testing market by technology 8.3.7. Europe coagulation testing market by end user 8.4. ASIA-PACIFIC 8.4.1. Key market trends 8.4.2. Key growth factors and opportunities 8.4.3. Market size and forecast 8.4.3.1. Japan market size and forecast 8.4.3.2. China market size and forecast 8.4.3.3. Australia market size and forecast 8.4.3.4. India market size and forecast 8.4.3.5. South Korea market size and forecast 8.4.3.6. Taiwan market size and forecast 8.4.3.7. Rest of Asia-Pacific market size and forecast 8.4.4. Asia-Pacific coagulation testing market by product 8.4.5. Asia-Pacific coagulation testing market by application 8.4.6. Asia-Pacific coagulation testing market by technology 8.4.7. Asia-Pacific coagulation testing market by end user 8.5. LAMEA 8.5.1. Key market trends 8.5.2. Key growth factors and opportunities 8.5.3. Market size and forecast 8.5.3.1. Brazil market size and forecast 8.5.3.2. Turkey market size and forecast 8.5.3.3. Saudi Arabia market size and forecast 8.5.3.4. South Africa market size and forecast 8.5.3.5. Rest of LAMEA market size and forecast 8.5.4. LAMEA coagulation testing market by product 8.5.5. LAMEA coagulation testing market by application 8.5.6. LAMEA coagulation testing market by technology 8.5.7. LAMEA coagulation testing market by end user
Chapter: 9 COMPANY PROFILES 9.1. ALERE INC. 9.1.1. Operating business segments 9.1.2. Business performance 9.1.3. Key strategic moves and developments 9.2. NIHON KOHDEN CORPORATION 9.2.1. Operating business segments 9.2.2. Business performance 9.2.3. Key strategic moves and developments 9.3. F. HOFFMANN-LA ROCHE LTD. 9.3.1. Operating business segments 9.3.2. Business performance 9.3.3. Key strategic moves and developments 9.4. SYSMEX CORPORATION 9.4.1. Operating business segments 9.4.2. Business performance 9.4.3. Key strategic moves and developments 9.5. THERMO FISHER SCIENTIFIC INC. 9.5.1. Operating business segments 9.5.2. Business performance 9.5.3. Key strategic moves and developments 9.6. DIAGNOSTICA STAGO SAS 9.6.1. Operating business segments 9.6.2. Business performance 9.6.3. Key strategic moves and developments 9.7. HELENA LABORATORIES 9.7.1. Operating business segments 9.7.2. Business performance 9.7.3. Key strategic moves and developments 9.8. ABBOTT LABORATORIES 9.8.1. Operating business segments 9.8.2. Business performance 9.8.3. Key strategic moves and developments 9.9. MEDTRONIC PLC 9.9.1. Operating business segments 9.9.2. Business performance 9.9.3. Key strategic moves and developments 9.10. MICROPOINT BIOSCIENCES 9.10.1. Operating business segments 9.10.2. Business performance 9.10.3. Key strategic moves and developments

Purchase Options